Healthcare -
Biotechnology - NASDAQ - US
$ 2.24
-6.28 %
$ 160 M
Market Cap
-0.9
P/E
ZNTL - OTHER LONG-TERM ASSETS
Other Long-term Assets ZNTL - Zentalis Pharmaceuticals, Inc.
9.5 M
LAST VALUE
90.16%
2 YEAR CAGR
44.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR